Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
Extreme itching, bleeding; Bleeding; This non-serious case was reported by a consumer and described the occurrence of pruritus in a 71-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included cardiac stent placement (Heart stent operation in January). Concurrent medical conditions included blood pressure high and blood cholesterol increased. Concomitant products included prasugrel hydrochloride (Effient), morniflumate (Flomax), rosuvastatin, losartan, acetylsalicylic acid (Asprin), pantoprazole sodium (Pantoprazole) and vitamins. On 12-MAY-2025, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pruritus (Verbatim: Extreme itching, bleeding) and hemorrhage (Verbatim: Bleeding). The patient was treated with hydrocortisone acetate;pramocaine hydrochloride (Hydroxine). The outcome of the pruritus and hemorrhage were not resolved. It was unknown if the reporter considered the pruritus and hemorrhage to be related to Shingrix. It was unknown if the company considered the pruritus and hemorrhage to be related to Shingrix. Additional Information: GSK Receipt Date: 18-MAY-2025 The patient was also on Effient for a heart stent operation in January. Other medications were reported as one a day Vitamin, Flomax, Hydroxine, Rousuvastatin, Losartan, Asprin, Pantoprozole. The patient wanted to know if this was a reaction to Shingrix and how long it would last. If there was any antidotes to cancel the allergic reaction. (Extreme itching, bleeding) Were the symptoms treated was reported as no.
Blood cholesterol increased; Blood pressure high
Medical History/Concurrent Conditions: Cardiac stent placement (Heart stent operation in January)
EFFIENT; Flomax; ROSUVASTATIN; LOSARTAN; ASPRIN; Pantoprazole; VITAMINS